Literature DB >> 23747866

Octamer-binding transcription factors: genomics and functions.

Feng-Qi Zhao1.   

Abstract

The Octamer-binding proteins (Oct) are a group of highly conserved transcription factors that specifically bind to the octamer motif (ATGCAAAT) and closely related sequences in promoters and enhancers of a wide variety of genes. Oct factors belong to the larger family of POU domain factors that are characterized by the presence of an amino-terminal specific subdomain (POUS) and a carboxyl-terminal homeo-subdomain (POUH). Eleven Oct proteins have been named (Oct1-11), and currently, eight genes encoding Oct proteins (Oct1, Oct2, Oct3/4, Oct6, Oct7, Oct8, Oct9, and Oct11) have been cloned. Oct1 and Oct2 are widely expressed in adult tissues, while other Oct proteins are much more restricted in their expression patterns. Oct proteins are implicated in crucial and versatile biological events, such as embryogenesis, neurogenesis, immunity, and body glucose and amino acid metabolism. The aberrant expression and null function of Oct proteins have also been linked to various diseases, including deafness, diabetes and cancer. In this review, I will report both the genomic structure and major functions of individual Oct proteins in physiological and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23747866      PMCID: PMC4349413          DOI: 10.2741/4162

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  194 in total

Review 1.  Immunoglobulin gene transcription.

Authors:  L M Staudt; M J Lenardo
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  The class III POU domain protein Brn-1 can fully replace the related Oct-6 during schwann cell development and myelination.

Authors:  Ralf P Friedrich; Beate Schlierf; Ernst R Tamm; Michael R Bösl; Michael Wegner
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  The molecular basis of X-linked deafness type 3 (DFN3) in two sporadic cases: identification of a somatic mosaicism for a POU3F4 missense mutation.

Authors:  Y J de Kok; C W Cremers; H H Ropers; F P Cremers
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

4.  Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.

Authors:  Shidou Zhao; Qiuhuan Yuan; Hongbo Hao; Yuji Guo; Shangming Liu; Yanmin Zhang; Jianli Wang; Huijuan Liu; Fuwu Wang; Kai Liu; Eng-Ang Ling; Aijun Hao
Journal:  J Pathol       Date:  2011-02-21       Impact factor: 7.996

5.  Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.

Authors:  Irina Berlin; Laurence Denat; Anne-Lise Steunou; Isabel Puig; Delphine Champeval; Sophie Colombo; Karen Roberts; Elise Bonvin; Yveline Bourgeois; Irwin Davidson; Véronique Delmas; Laurence Nieto; Colin R Goding; Lionel Larue
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

6.  Examination of POU homeobox gene expression in human breast cancer cells.

Authors:  T Jin; D R Branch; X Zhang; S Qi; B Youngson; P E Goss
Journal:  Int J Cancer       Date:  1999-03-31       Impact factor: 7.396

7.  Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.

Authors:  D Re; M Müschen; T Ahmadi; C Wickenhauser; A Staratschek-Jox; U Holtick; V Diehl; J Wolf
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

Review 8.  POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.

Authors:  Anthony L Cook; Richard A Sturm
Journal:  Pigment Cell Melanoma Res       Date:  2008-10-22       Impact factor: 4.693

9.  Cell-cycle regulation of a human histone H2b gene is mediated by the H2b subtype-specific consensus element.

Authors:  F LaBella; H L Sive; R G Roeder; N Heintz
Journal:  Genes Dev       Date:  1988-01       Impact factor: 11.361

10.  The DNA binding specificity of the bipartite POU domain and its subdomains.

Authors:  C P Verrijzer; M J Alkema; W W van Weperen; H C Van Leeuwen; M J Strating; P C van der Vliet
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  17 in total

1.  Method of isolation and characterization of Girardia tigrina stem cells.

Authors:  K A R Lopes; N M R DE Campos Velho; C Pacheco-Soares
Journal:  Biomed Rep       Date:  2014-12-19

2.  Expression profiling of Tas2r genes reveals a complex pattern along the mouse GI tract and the presence of Tas2r131 in a subset of intestinal Paneth cells.

Authors:  Simone Prandi; Anja Voigt; Wolfgang Meyerhof; Maik Behrens
Journal:  Cell Mol Life Sci       Date:  2017-08-11       Impact factor: 9.261

3.  A cis-Acting Element Downstream of the Mouse Mammary Tumor Virus Major Splice Donor Critical for RNA Elongation and Stability.

Authors:  Shaima Akhlaq; Neena G Panicker; Pretty S Philip; Lizna M Ali; Jaquelin P Dudley; Tahir A Rizvi; Farah Mustafa
Journal:  J Mol Biol       Date:  2018-09-01       Impact factor: 5.469

4.  A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-Jκ to the virus genome.

Authors:  Olga Gonzalez-Lopez; Jennifer DeCotiis; Corey Goyeneche; Helena Mello; Bryan Alexis Vicente-Ortiz; Hye Jin Shin; Kyla E Driscoll; Peicheng Du; Diana Palmeri; David M Lukac
Journal:  J Biol Chem       Date:  2019-07-15       Impact factor: 5.157

Review 5.  The functional diversity of the POUV-class proteins across vertebrates.

Authors:  Evgeny I Bakhmet; Alexey N Tomilin
Journal:  Open Biol       Date:  2022-06-29       Impact factor: 7.124

6.  Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells.

Authors:  Megan Beetch; Cayla Boycott; Sadaf Harandi-Zadeh; Tony Yang; Benjamin J E Martin; Thomas Dixon-McDougall; Kevin Ren; Allison Gacad; John H Dupuis; Melissa Ullmer; Katarzyna Lubecka; Rickey Y Yada; Carolyn J Brown; LeAnn J Howe; Barbara Stefanska
Journal:  J Nutr Biochem       Date:  2021-07-07       Impact factor: 6.048

7.  Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.

Authors:  Michele Scarola; Elisa Comisso; Rhena Pascolo; Riccardo Chiaradia; Rosa Maria Marion; Claudio Schneider; Maria A Blasco; Stefan Schoeftner; Roberta Benetti
Journal:  Nat Commun       Date:  2015-07-09       Impact factor: 14.919

8.  Different N-terminal isoforms of Oct-1 control expression of distinct sets of genes and their high levels in Namalwa Burkitt's lymphoma cells affect a wide range of cellular processes.

Authors:  Elizaveta V Pankratova; Alexander G Stepchenko; Tatiana Portseva; Vladic A Mogila; Sofia G Georgieva
Journal:  Nucleic Acids Res       Date:  2016-07-12       Impact factor: 16.971

9.  Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2.

Authors:  Eusebio Chiefari; Biagio Arcidiacono; Katiuscia Possidente; Stefania Iiritano; Valeria Ventura; Rosantony Pandolfo; Francesco Saverio Brunetti; Manfredi Greco; Daniela Foti; Antonio Brunetti
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

10.  Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta.

Authors:  Laura Bianchi; Assunta Gagliardi; Silvia Maruelli; Roberta Besio; Claudia Landi; Roberta Gioia; Kenneth M Kozloff; Basma M Khoury; Paul J Coucke; Sofie Symoens; Joan C Marini; Antonio Rossi; Luca Bini; Antonella Forlino
Journal:  Hum Mol Genet       Date:  2015-08-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.